A research team, led by Dr. Ugo Cavallaro and supported by OCRA’s 2019 Collaborative Research Development Grant, made progress toward improving immunotherapies for ovarian cancer. Dr. Frances R. Balkwill, a collaborator on that team, carried this work forward, contributing to findings recently published in the American Association for Cancer Research (AACR) journal. The study explores … Continued
Leaders in the patient advocacy space came together for a wide-ranging study on the often-overlooked challenges faced by caregivers of cancer patients, with Tracy Moore, LCSW, who serves as Ovarian Cancer Research Alliance’s Vice President, Support & Education, contributing on behalf of the gynecologic cancer community. Published in Future Oncology, the study identifies four critical … Continued
A study published in Nature Cancer details how OCRA-funded research has dramatically expanded the impact of DNA and RNA data in the Cancer Genome Atlas and Cancer Cell Line Encyclopedia, by analyzing samples for protein expression related to cancer. The research team behind the study includes Dr. Gordon Mills, an Ovarian Cancer Research Alliance grantee … Continued
Record number of applications received Ovarian Cancer Research Alliance (OCRA) announced today that it will invest $6 million for research projects to begin in 2025, which includes promising projects targeting recurrence, treatment resistance, outcome disparities and other challenges faced by our community. These grantees were selected from a record number of applicants via a competitive … Continued
OCRA’s 2024 Mentored Investigator Grants are supporting fresh perspectives and approaches to end ovarian and related gynecologic cancers. This year’s grants are awarded to 5 exceptional young researchers who are conducting promising studies under the mentorship of leaders in the gynecologic cancer field. “OCRA’s Mentored Investigators exemplify the innovative spirit and dedication needed to make … Continued
OCRA’s 2024 Early Career Investigator Grants are awarded to 8 outstanding young researchers with a strong commitment to ending ovarian and related gynecologic cancers. These grants fund innovative projects, and support the next generation of scientists dedicated to curing ovarian cancer. “By supporting these early career investigators, we’re fostering innovative approaches and fresh perspectives into … Continued
OCRA’s Health Equity Research Grants for 2024 are dedicated to advancing equity in care of ovarian and related gynecologic cancers, addressing deep disparities in early diagnosis, access to care, and patient outcomes. “In a year of remarkable new research being undertaken by OCRA-funded scientists, our expanded focus on health equity is more critical than ever,” … Continued
OCRA’s four Collaborative Research Development Grants, including a partnership grant through Microsoft AI for Health, are multi-investigator studies set to tackle the most pressing issues in research, treatment and care. “In an all-around stellar crop of new OCRA-funded research for 2024, our collaborative studies hold particular promise,” says Audra Moran, OCRA’s President & CEO. “By … Continued
Research breakthroughs are around the corner. In 2023, OCRA announced $9.2 million in research initiatives for 2024 — the largest in our history — including awarding 20 grants to scientists at 15 prestigious institutions. Recommended for funding by OCRA’s Scientific Advisory Committee from a competitive evaluation process, these exceptional researchers and their forward-thinking studies will tackle … Continued
An OCRA research team is using Artificial Intelligence (AI) to develop a blood test to potentially detect ovarian cancer, as part of an OCRA-funded study in partnership with Microsoft AI for Good Lab. OCRA grantee Daniel Heller, PhD, lead researcher at The Daniel Heller Lab at Memorial Sloan Kettering Cancer Center discusses this cutting-edge technology … Continued
Livnat Jerby, PhD, is Assistant Professor in the Department of Genetics at Stanford University and a 2022 recipient of OCRA’s Early Career Investigator Grant. Through her OCRA-funded project, she is utilizing cutting-edge technologies to gain new insights into the specific mechanisms that allow ovarian cancer to escape the immune system. She aims to pave the way to … Continued
Ovarian Cancer Research Alliance (OCRA), the world’s largest ovarian cancer charity, announced today the 2023 winners of the Rosalind Franklin Prize for Excellence in Ovarian Cancer Research and the Schreiber Research Prize for Outstanding Mentored Investigators. One recipient is being recognized for her noteworthy leadership in the field, which includes seminal work in novel therapeutics … Continued
Get email updates about research news, action alerts, and ways to join the fight.
